Most Read This Week
- Amitriptyline at Low-Dose and Titrated for Irritable Bowel Syndrome as Second-Line Treatment in Primary Care
- Importance of Compassion in Healthcare
- Diagnostic Performance of Faecal Calprotectin Level in Distinguishing Inflammatory Bowel Disease From Irritable Bowel Syndrome in Adults
- 10-Day Vonoprazan–Amoxicillin Dual Therapy vs Standard Bismuth-Based Quadruple Therapy for the First-Line Eradication of H pylori Infection
- Number of Biopsies Required for Accurate Histological Assessment of Inflammation in Active Ulcerative Colitis
Recently Updated
- Doxycycline Tied to Lower Risk for C. Difficile in Pneumonia Patients
- Abdominal Pain in Patients With IBD in Remission
- Magnetic Resonance Elastography–Based Prediction Model for Hepatic Decompensation in Patients With NAFLD
- Novel Symptom Clusters Predict Disease Impact and Healthcare Utilisation Among Patients With IBD
- Recent Decline in Risk for CRC Recurrence Seen in Stage I to III Disease